CYTOKINETICS INC — Director's Dealing 2025

Oct 16, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2025-10-15

Reporting Person: Kaye Edward M. MD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-10-15	Common Stock	A	199	$62.80	Acquired	9977	Direct

Footnotes

F1: Director equity in lieu of cash retainer program.